biomedicina slovenica


"Hypercholesterolemia" : 212

  1. Ceška R.; Paragh György; Reiner Željko; Banach Maciej; Tokgözoğlu Lale; Susekov Andrey V.; Rašlová Katarína; Freiberger Tomas; Vohnout Branislav; Rynkiewicz Andrzej; Fras Zlatko
    ScreenPro FH - screening project for familial hypercholesterolemia in Central, Southern and Eastern Europe
    2017
  2. Ceška R.; Freiberger Tomas; Susekov Andrey V.; Paragh György; Reiner Željko; Tokgözoğlu Lale; Rašlová Katarína; Banach Maciej; Vohnout Branislav; Rynkiewicz Andrzej; Fras Zlatko
    ScreenPro FH - screening project for familial hypercholesterolemia in Central, Southern and Eastern Europe
    2017
  3. Josipović Božo; Jablanovic D. D. J.; Nedeljkovic R.; Ilic S.
    Unrecognized seropositive RA and SS in a patient with associated familial hypercholesterolemia type IIa and osseous xanthoma of the proximal femur
    2003
  4. Marčun-Varda Nataša; Nikolić Sara; Močnik Mirjam
    Subendocardial viability ratio and ejection duration as parameters of early cardiovascular risk in children
    2017
  5. Anžič Ajda; Grošelj Urh; Skarlovnik Ajda
    Ocenjevanje tveganja za srčno-žilna obolenja pri osebah z družinsko hiperholesterolemijo
    [Cardiovascular risk assessment in individuals with familial hypercholesterolemia]
    2017
  6. Marazzi Giuseppe; Pelliccia Francesco; Campolongo Giuseppe; Cacciotti Luca; Poggi Sara; Tanzilli Alessandra; Di Iorio Martina; Volterrani Maurizio; Lainščak Mitja; Rosano Giuseppe M.
    Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial
    2016
  7. Klančar Gašper; Battelino Tadej; Trebušak Podkrajšek Katarina
    Genetske značilnosti hiperholesterolemij pri otrocih in mladostnikih v Sloveniji
    [Genetic charateristics of hypercholesterolemia in children and adolescents in Slovenia]
    2016
  8. Atanasijević-Kunc Maja; Drinovec Jože; Ručigaj Simona; Mrhar Aleš
    Matematični model vpliva bolezni in dejavnikov tveganja na razvoj možganske kapi
    2007
  9. Mičetić-Turk Dušanka; Šikić Pogačar Maja; Marčun-Varda Nataša; Dolinšek Jernej; Urlep Žužej Darja
    The impact of overweight and obesity on health-related quality-of-life among children and adolescents in Slovenia
    2008
  10. Obesity, familial hypercholesterolemia
    2008
  11. Klančar Gašper; Grošelj Urh; Kovač Jernej; Bratanič Nevenka; Bratina Nataša; Battelino Tadej; Trebušak Podkrajšek Katarina
    Implementation of next generation sequencing in national universal hypercholesterolemia screening
    2015
  12. Klančar Gašper; Grošelj Urh; Kovač Jernej; Bratanič Nevenka; Bratina Nataša; Trebušak Podkrajšek Katarina; Battelino Tadej
    Universal screening for familial hypercholesterolemia in children
    2015
  13. Klančar Gašper; Trebušak Podkrajšek Katarina
    Opredelitev genskih vzrokov hiperholesterolemij
    [Determination of genetic causes of hypercholesterolemia]
    2014
  14. Klančar Gašper; Grošelj Urh; Bratina Nataša; Bratanič Nevenka; Battelino Tadej; Trebušak Podkrajšek Katarina
    The LDLR gene analysis in the slovene familial hypercholesterolemia (fh) population
    2012
  15. Grošelj Urh; Klančar Gašper; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Some characteristics of the Slovene familial hypercholesterolemia (FH) pediatric population
    2012
  16. Kovač Urša; Košir Rok; Fužir Natalija; Lewinska Monika; Kovač Jernej; Klančar Gašper; Trebušak Podkrajšek Katarina; Kotnik Primož; Battelino Tadej; Rozman Damjana
    PNPLA3 as a potential marker for non-alcoholic fatty liver disease in children with familial hypercholesterolemia?
    2015
  17. Klančar Gašper; Grošelj Urh; Bratina Nataša; Trebušak Podkrajšek Katarina; Battelino Tadej
    LDLR and APOB gene analysis in the Slovene population of the children and adolescents with hypercholesteromia
    2013
  18. Klančar Gašper; Malovrh Petra; Grošelj Urh; Bratanič Nevenka; Bratina Nataša; Božič Mojca; Cevc Matija; Battelino Tadej; Trebušak Podkrajšek Katarina
    Familial defective apolipoprotein B-100
    2014
  19. Klančar Gašper; Grošelj Urh; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Genetic characteristics of hypercholesterolemia in children and adolescents in Slovenia
    2013
  20. Grošelj Urh; Klančar Gašper; Bratina Nataša; Bratanič Nevenka; Trebušak Podkrajšek Katarina; Battelino Tadej
    Clinical and genetic characteristics of the paediatric heterozygous familial hypercholesterolaemia population in Slovenia: a preliminary report
    2013
  21. Ponikvar Rafael; Žugić Ratko; Dedić Hasan; Gaber Liljana; Buturović-Ponikvar Jadranka; Kovač Janko; Premru Vladimir; Benedik Miha; Marn-Pernat Andreja; Gubenšek Jakob; Poljančič A; Knap Bojan
    22 years of LDL apheresis in a patient with familial homozigous hypercholesterolemia
    2012
  22. Kusters DM; de Beaufort C; Widhalm K; Guardamagna O; Bratina N; Ose L; Wiegman A
    Paediatric screening for hypercholesterolaemia in Europe
    2012
  23. Poredoš Pavel; Ježovnik Mateja Kaja
    Dyslipidemia, statins, and venous thromboembolism
    2011
  24. Režen Tadeja
    The impact of cholesterol and its metabolites on drug metabolism
    2011
  25. Lunder Mojca; Žiberna Lovro; Drevenšek Gorazd; Šabovič Mišo
    Zaščitni pleiotropni učinki statinov
    [Beneficial pleiotropic effects of statins]
    2011
  26. Tušek-Bunc Ksenija; Kersnik Janko; Petek-Šter Marija; Petek Davorina; Klemenc-Ketiš Zalika
    Explanatory model of prescribing behavior in prescription of statins in family practice
    2010
  27. Pietroleonardo L; Ruzicka T
    Skin manifestations in familial heterozygous hypercholesterolemia
    2009
  28. Premru V; Ponikvar R
    LDL apheresis in two children with homozygous familiar hypercholesterolemia
    2009
  29. Bregar U; Poredoš P; Šabovič M; Jug B; Šebeštjen M
    The influence of atorvastatin on walking performance in peripheral arterial disease
    2009
  30. Kuzman Drago; Fon Tacer Klementina; Černe M; Režen Tadeja; Ačimovič Jure; Čegovnik Urška; Kocjan Darko; Urleb Uroš; Rozman Damjana
    Modulation of hepatic transcriptomein the poloxamer P-407 hyperlipidemia mouse model
    2009
  31. Bregar Urška
    Hemodinamski učinki statinov pri bolnikih s periferno arterijsko boleznijo: magistrsko delo
    2008
  32. Premru V; Ponikvar R
    LDL apheresis in two children with homozygous familiar hypercholesterolemia
    2008
  33. Atanasijević-Kunc Maja; Drinovec Jože; Ručigaj Simona; Mrhar Aleš
    Modelling of the risk factors and chronic diseases that influence the development of serious health complications
    [Modeliranje dejavnikov tveganja in kroničnih bolezni, ki vplivajo na razvoj hujših zdravstvenih zapletov]
    2008
  34. Barbič-Žagar Breda; Kos Jernej; Grošelj Mateja
    Klinične izkušnje z atorvastatinom v visokih odmerkih
    [Clinical experience with high doses of atorvastatin]
    2007
  35. Kohalmy Krisztina; Rozman Damjana; Pascussi Jean-Marc; Sarvary Eniko; Monostory Katalin
    A koleszterinhomeosztazis es a gyogyszer-metabolizmus kapcsolata
    [Crosstalk between cholesterol homeostasis and drug metabolism]
    2008
  36. Pregelj Peter
    Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins
    2008
  37. Vrtovec B; Okrajšek R; Goličnik A; Ferjan M; Starc V; Schlegel TT; Radovancevic B
    Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure
    2008
  38. Poredoš P
    Secondary prevention of peripheral arterial disease with drugs
    2007
  39. Nicholls Stephen J; Tuzcu E Murat; Sipahi Ilke; Grasso Adam W; Schoenhagen Paul; Hu Tingfei; Wolski Kathy; Crowe Tim; Desai Milind Y; Hazen Stanley L
    Statini, holesterol v lipoproteinih velike gostote in regresija koronarne ateroskleroze
    [Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis]
    2007
  40. Fras Zlatko
    Je mogoče s statini zavreti ali celo (o)zdraviti aterosklerozo?
    2007
  41. Kenda Miran F.; Fras Zlatko
    25. Radenski dnevi. Program in zbornik prispevkov: jubilejno tradicionalno letno strokovno srečanje Združenja kardiologov Slovenije; 2007 maj 24-26; Radenci
    2007
  42. Lainščak Mitja; von Haehling Stephan; Springer Jochen; Anker Stefan D
    Biomarkers for chronic heart failure
    2007
  43. Fras Zlatko
    Preventivni ukrepi in zdravljenje dislipidemij pri bolniku po prebolelem srčnem infarktu
    2007
  44. Bulc Mateja
    Why men?
    2001
  45. Bedernjak-Bajuk Nataša
    Sladkorna bolezen - tveganje za nastanek akutnega infarkta srca
    2000
  46. Žemva Aleš; Benca Maja
    From endothelial dysfunction to hypertension
    [Od endotelijske disfunkcije do hipertenzije]
    2006
  47. Gomez MI; Perez B; Contreras JA; de Las Heras MH; Rocamora A; Ledo A
    Xanthoma disseminatum associated with hypocholesterolemia and hypolipoproteinemia
    1994
  48. Del Rio M; Chulia T; Merchan-Perez A; Remezal M; Valor S; Gonzalez J; Gutierrez JA; Contreras JA; Lasuncion MA; Tejerina T
    Effects of indapamide on atherosclerosis development in cholesterol-fed rabbits
    1995
  49. Eržen Barbara; Gradišek Primož; Poredoš Pavel; Šabovič Mišo
    Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries
    2006
  50. Dajčman Davorin
    Bolnik z mešano hiperlipidemijo, periferno okluzivno arterijsko boleznijo in prsno bolečino - prikaz primera
    [Patient with mixed hyperlipidemia, peripheral occlusive arterial disease and chest pain - case report]
    2006
  51. Završnik Matej
    Motnje v presnovi maščob
    [Dyslipidemia]
    2006
  52. Lainščak Mitja; Fras Zlatko
    Ali je nefarmakološka obravnava hiperholesterolemije lahko učinkovita? Rezultati raziskave Becel Pro.Activ v Sloveniji
    2006
  53. Cevc Matija
    Farmakoekonomika zdravljenja dislipedemij pri bolnikih z akutnim koronarnim sindromom
    [Pharmacoeconomics of dyslipidemia treatment in patients with acute coronary syndrome]
    2006
  54. Fras Zlatko
    Učinkovitost kombiniranega zdravljenja hiperholesterolemije s statini in ezetimibom - prikaz rezultatov raziskave SI-SPECT
    [Effectiveness of combined statin plus ezetimibe treatment of hypercholesterolemia - presentation of SI-SPECT programme results]
    2006
  55. Lainščak Mitja; Fras Zlatko
    Nefarmakološki ukrepi ob hiperholesterolemiji - ali imamo nove možnosti?
    2006
  56. Šabovič Mišo
    Zdravljenje stabilne angine pektoris s statini
    2006
  57. Binbrek Azan S; Elis Avishay; Al-Zaibag Muayed; Eha Jaan; Keber Irena; Cuevas Ada M; Mukherjee Swati; Miller Thomas R
    Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: a randomized, open-label, parallel-group, multicenter study (DISCOVERY alpha study)
    2006
  58. Fras Zlatko
    Kako obravnavamo dislipidemije v Sloveniji?
    2006
  59. Cevc Matija
    Farmakoekonomske osnove zdravljenja dislipidemij
    2006
  60. Černe Andreja
    Maščobe v krvi
    2005
  61. Fras Zlatko
    Obravnava dislipidemije pri metaboličnem sindromu
    2005
  62. Bešlić Šerif; Dalagija Faruk
    Coronary artery calcium scoring in myocardial infarction
    [Ugotavljanje koronarne kalcifikacije pri miokardnem infarktu]
    2005
  63. Štubler Mira
    Zdravstvena nega po operaciji in svetovanje glede zdravega načina življenja
    2005
  64. Černe Andreja; Kranjec Igor; Peterlin Borut
    Angiotensin-converting enzyme gene polymorphism and acute coronary syndrome
    [Polimorfizmi gena za encim angiotenzinsko konvertazo pri bolnikih z akutnim koronarnim sindromom]
    2005
  65. Medvešček Marko
    Sladkorna bolezen tipa 2 - pandemija 21. stoletja
    2004
  66. Tasič Janez
    Zniževanje holesterola - dieta namesto zdravil!
    2003
  67. Hlastan-Ribič Cirila
    Tudi rastlinske maščobe so lahko škodljive
    2003
  68. Uršič-Bratina Nataša; Bratanič Nina; Battelino Tadej
    Nevarne povišane maščobe v krvi otroka
    2003
  69. Blinc Aleš
    Sistematično izmišljanje novih bolezni?
    2003
  70. Bombek Mirko
    Koliko smo naredili za preprečevanje bolezni srca in ožilja?
    2002
  71. Pavčič Maruša
    S fitosteroli nad holesterol
    2001
  72. Cevc Matija
    Povišana raven holesterola v krvi v poznejših letih
    2005
  73. Bratanič Nevenka; Vesel Samo; Uršič-Bratina Nataša; Žerjav-Tanšek Mojca; Sedmak Marjeta; Kržišnik Ciril; Battelino Tadej
    Familiarna hiperholesterolemija
    2005
  74. Šebeštjen Miran
    Novi dejavniki tveganja za aterosklerozo: pomen in možnosti zdravljenja
    2005
  75. Pintar Tatjana
    Vpliv statinov na pooperativne zaplete pri bolnikih po kirurški revaskularizaciji venčnih arterij
    2005
  76. Grad Anton; Žvan Bojana
    Možganska kap v Sloveniji upada
    2001
  77. Rotovnik-Kozjek Nada
    Prehrana, gibanje in zdravje
    2005
  78. Zaletel-Kragelj Lijana; Fras Zlatko
    Stanje gibanja za zdravje pri odraslih prebivalcih v Sloveniji. Rezultati skupne raziskave CINDI Slovenije in projekta CRP Gibalna/športna aktivnost za zdravje
    2005
  79. Goličnik Alenka; Ferjan Mateja
    Vpliv atorvastatina na trajanje intervala QTC pri bolnikih s srčnim popuščanjem
    2004
  80. Tomažič Janez; Silič Anja; Karner Primož; Vidmar Ludvik; Matičič Mojca; Poljak Mario; Ihan Alojz; Janež Andrej
    Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients
    2004
  81. Poredoš Pavel
    Involvement of endothelial dysfunction in atherogenesis
    2004
  82. Poredoš Pavel; Blinc Aleš
    What is new in angiology?
    2005
  83. Strasser Thomas
    Epidemiologija hipertenzije
    2004
  84. Dolenc Ester
    Razširjenost dejavnikov tveganja za kronične nenalezljive bolezni v vzorcu odraslih oskrbovancev Splošne ambulante Miren-Kostanjevica na Krasu v letu 2002
    2004
  85. Poredoš Pavel
    Periferna arterijska bolezen in hiperlipidemija
    [Peripheral artery disease and dyslipidemia]
    2004
  86. Žvan Bojana; Zaletel Marjan
    Možganskožilne bolezni pri ženskah
    2004
  87. Barbič-Žagar Breda
    Učinkovitost in varnost Vasilipa pri bolnikih s hiperholesterolemijo
    [The efficacy and safety of Vasilip in patients with hypercholesterolemia]
    2002
  88. Reiner Željko; Tedeschi-Reiner Eugenia
    Vloga statinov v preprečevanju srčno-žilnih bolezni
    [The role of statins in the prevention of cardiovascular diseases]
    2002
  89. Barbič-Žagar Breda; Drinovec Jože
    Predgovor
    2002
  90. Marušič Andrej
    Osebnostni profil in izpostavljenost stresu pri koronarografiranih bolnikih z angino pektoris
    1992
  91. Vrečer M; Turk S; Drinovec J; Mrhar A
    Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke: meta-analysis of randomized trials
    2003
  92. Eržen Barbara
    Endotelijska disfunkcija pri mladih moških po prebolelem srčnem infarktu
    2003
  93. Uršič-Bratina Nataša; Bratanič Nina; Žerjav-Tanšek Mojca; Kržišnik Ciril; Battelino Tadej
    The results of the screening for hypercholesterolemia in 5 year old children in Slovenia
    2002
  94. Oguchi S; Dimayuga P; Chyu K-Y; Zhu J; Shah PK; Nilsson J; Čerček B
    VCAM-1 regulation after arterial wall injury
    2000
  95. Naqvi T; Shah PK; Ivey PA; Molloy MD; Thomas AM; Panicker S; Ahmed A; Čerček B; Kaul S
    Evidence that HDL is an independent predictor of acute platelet-dependent thrombus formation
    1999
  96. Dimayuga P; Zhu J; Oguchi S; Chyu KY; Yano J; Shah PK; Nilsson J; Čerček B
    Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff induced carotid injury in apoE null mice
    1999
  97. Nilsson J; Calara R; Regnstrom JR; Hultgardh-Nilsson A; Ameli S; Čerček B; Shah PK
    Immunization with homologous oxidized low density lipoprotein reduces neointima formation following balloon-injury in hypercholesterolemic rabbits
    1997
  98. Ameli S; Hultgardh-Nilsoon A; Regnstrom J; Calara F; Čerček B; Shah PK; Nilsson J
    Effect of immunization with homologous unmodified and oxidized low density lipoprotein on early atherosclerosis in hypercholesterolemic rabbits
    1996
  99. Ameli S; Hultgardh-Nilsson A; Čerček B; Shah PK; Forrester JS; Ageland H; Nilsson J
    Recombinant apolipoprotein A-I Milano reduces intimal thickening following balloon-injury in hypercholesterolemic rabbits
    1994
  100. Dugonik A; Belič M; Miljković J
    Eosinophilic fasciitis
    2003

1 101 201  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics